References
- Rendon M, Berneburg AF, Arellano I, et al. Treatment of melasma. J Am Acad Dermatol. 2006;54(5):272–281. doi:10.1016/j.jaad.2004.09.015.
- Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett. 2006;11:1–6.
- Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched Alexandrite laser: a pilot study. Dermatol Surg. 1999;25(6):494–497. doi:10.1046/j.1524-4725.1999.08248.x.
- Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched Alexandrite laser compared with Q-switched Alexandrite laser alone for refractory melasma: split-face “design”. Dermatol Surg. 2003;29(1):59–64. doi:10.1046/j.1524-4725.2003.29009.x.
- Arora P, Sarkar R, Garg VK, Arya L. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthet Surg. 2012;5(2):93–103. doi:10.4103/0974-2077.99436.
- Goldberg DJ. Berlin AL and Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Laser Surg Med. 2008;40(2):134–138. doi:10.1002/lsm.20591.
- Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(1):78–83. doi:10.1016/j.jaad.2009.10.051.
- Bozzola JJ, Russell LD. Electron Microscopy: Principles and Techniques for Biologists. Boston: Jones and Bartlett; 1999:670.
- Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237. doi:10.1046/j.0007-0963.2001.04556.x.
- Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol. 2009;54(4):303–309. doi:10.4103/0019-5154.57602.
- Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65(4):699–714. doi:10.1016/j.jaad.2011.06.001.
- Neeley MR. Pearce FB and Collawn SS. Successful treatment of malar dermal melasma with a fractional ablative CO2 laser in a patient with type V skin. J Cosmet Laser Ther. 2010;12(6):258–260. doi:10.3109/14764172.2010.538412.
- Jalaly NY, Valizadeh N, Barikbin B, et al. Low-power fractional CO 2 laser versus low-fluence Q-switch 1,064 nm Nd: YAGLaser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol. 2014;15(4):357–363. doi:10.1007/s40257-014-0080-x.
- De Mattos Diosti G, Mulinari-Brenner F, Neto JF, et al. Clinical and histological evaluation of patients with refractory melasma treated with fractional Erbium: YAGlaser. Surg Cosmet Dermatol. 2012;4(2):114–120.
- Tse Y, Levine VJ, Mcclain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Qswitched neodymium: yttrium-aluminum-garnetlaser: a comparative study. J Dermatol Surg Oncol. 1994;20:795–800. doi:10.1111/j.1524-4725.1994.tb03707.x.
- Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20:592–597. doi:10.1111/j.1524-4725.1994.tb00152.x.
- Kauvar ANB, Warycha MA. Wrinkles and Acne Scars: fractional ablative lasers. In: Christian Raulin and Syrus Karsai (eds.), Laser and IPL Technology in Dermatology and Aesthetic Medicine, Chapter 23. Springer Berlin Heidelberg; 2011:307–318.
- Hunzeker CM, Weiss ET, Geronemus RG. Fractionated CO2 laser resurfacing: our experience with more than 2000 treatments. Aesthet Surg J. 2009;29(4):317–322. doi:10.1016/j.asj.2009.05.004.